{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:35Z","timestamp":1790912495157,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T00:00:00Z","timestamp":1580688000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["115557"],"award-info":[{"award-number":["115557"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.vaccine.2020.01.100","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T10:51:22Z","timestamp":1581504682000},"page":"B8-B21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"S2","title":["ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1360-2388","authenticated-orcid":false,"given":"Miriam","family":"Sturkenboom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5637-4613","authenticated-orcid":false,"given":"Toon","family":"Braeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieke","family":"van der Aa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Danieli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Dodd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talita","family":"Duarte-Salles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne- Dorthe","family":"Emborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Gheorghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny","family":"Kahlert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4012-7826","authenticated-orcid":false,"given":"Consuelo","family":"Huerta-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Mart\u00edn-Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9964-4724","authenticated-orcid":false,"given":"Chris","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Picelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Roberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Tramontan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Weibel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Titievsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.01.100_b0005","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s40471-014-0026-0","article-title":"Opportunities and challenges in using epidemiologic methods to monitor drug safety in the era of large automated health databases","volume":"1","author":"Andrews","year":"2014","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.vaccine.2020.01.100_b0010","doi-asserted-by":"crossref","first-page":"B1","DOI":"10.1016\/j.vaccine.2019.07.081","article-title":"Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines","volume":"38","author":"Sturkenboom","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0015","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMp1809643","article-title":"The FDA sentinel initiative \u2014 an evolving national resource","volume":"379","author":"Platt","year":"2018","journal-title":"NEJM"},{"key":"10.1016\/j.vaccine.2020.01.100_b0020","doi-asserted-by":"crossref","first-page":"e023090","DOI":"10.1136\/bmjopen-2018-023090","article-title":"Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulation","volume":"8","author":"Pacurariu","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2020.01.100_b0025","doi-asserted-by":"crossref","first-page":"e021864","DOI":"10.1136\/bmjopen-2018-021864","article-title":"EU-funded initiatives for real world evidence: descriptive analysis of their characteristics and relevance for regulatory decision-making","volume":"8","author":"Plueschke","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2020.01.100_b0030","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/0098858818789429","article-title":"Real-world data analytics fit for regulatory decision-making","volume":"44","author":"Schneeweiss","year":"2018","journal-title":"Am J Law Med"},{"key":"10.1016\/j.vaccine.2020.01.100_b0035","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pds.4295","article-title":"Reporting to improve reproducibility and facilitate validity assessment for healthcare database studies V1.0","volume":"26","author":"Wang","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2020.01.100_b0040","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/pds.613","article-title":"The Vaccine Safety Datalink project","volume":"10","author":"DeStefano","year":"2001","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2020.01.100_b0045","doi-asserted-by":"crossref","first-page":"K98","DOI":"10.1016\/j.vaccine.2013.04.088","article-title":"Post-licensure rapid immunization safety monitoring program (PRISM) data characterization","volume":"31","author":"Baker","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/oxfordjournals.aje.a009785","article-title":"Quality of HMO vaccination databases used to monitor childhood vaccine safety. Vaccine Safety DataLink Team","volume":"149","author":"Mullooly","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2020.01.100_b0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/amiajnl-2012-000878","article-title":"Using EHRs to integrate research with patient care: promises and challenges","volume":"19","author":"Weng","year":"2012","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.vaccine.2020.01.100_b0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.vaccine.2020.01.100_b0065","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.12688\/f1000research.12198.1","article-title":"An analysis of characteristics of post-authorisation studies registered on the ENCePP EU PAS Register","volume":"6","author":"Carroll","year":"2017","journal-title":"F1000Research"},{"key":"10.1016\/j.vaccine.2020.01.100_b0070","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7326\/0003-4819-110-6-482","article-title":"The misinformation era: the fall of the medical record","volume":"110","author":"Burnum","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.vaccine.2020.01.100_b0075","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/clpt.1989.154","article-title":"The role of automated record linkage in the postmarketing surveillance of drug safety: a critique","volume":"46","author":"Shapiro","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.vaccine.2020.01.100_b0080","unstructured":"ADVANCE; 2018 [last accessed 20 June 2018]. Available from: http:\/\/www.advance-vaccines.eu\/."},{"key":"10.1016\/j.vaccine.2020.01.100_b0085","article-title":"The ADVANCE distributed network system for evidence generation on vaccines coverage, benefits and risks based on electronic health care data","author":"Sturkenboom","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0090","doi-asserted-by":"crossref","first-page":"B22","DOI":"10.1016\/j.vaccine.2019.07.039","article-title":"ADVANCE system testing: can coverage of pertussis vaccination be estimated in EU countries using electronic health data: an example","volume":"38","author":"Emborg","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0095","doi-asserted-by":"crossref","first-page":"B31","DOI":"10.1016\/j.vaccine.2019.08.078","article-title":"ADVANCE system testing: vaccine benefit studies by using multi-country electronic health data: An example on pertussis vaccination","volume":"38","author":"Tin Tin Htar","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0100","doi-asserted-by":"crossref","first-page":"B38","DOI":"10.1016\/j.vaccine.2019.06.040","article-title":"ADVANCE system testing: can safety studies be conducted using electronic health data: an example with pertussis vaccination?","volume":"38","author":"Weibel","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0105","doi-asserted-by":"crossref","first-page":"B47","DOI":"10.1016\/j.vaccine.2020.03.050","article-title":"ADVANCE system testing: estimating the incidence of adverse events following pertussis vaccination in healthcare databases with incomplete exposure data","volume":"38","author":"Dodd","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0110","doi-asserted-by":"crossref","first-page":"B56","DOI":"10.1016\/j.vaccine.2019.07.045","article-title":"Quantifying outcome misclassification in multi-database studies: the case study of pertussis in the ADVANCE project","volume":"38","author":"Gini","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0115","doi-asserted-by":"crossref","first-page":"B65","DOI":"10.1016\/j.vaccine.2019.09.034","article-title":"ADVANCE system testing: benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and cohort modelling","volume":"38","author":"Bollaerts","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0120","doi-asserted-by":"crossref","first-page":"B76","DOI":"10.1016\/j.vaccine.2019.08.012","article-title":"ADVANCE: towards near real-time monitoring of vaccination coverage, benefits and risk using European electronic health record databases","volume":"38","author":"Bollaerts","year":"2020","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2020.01.100_b0125","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/pds.4245","article-title":"CodeMapper: semiautomatic coding of case definitions. A contribution from the ADVANCE project","volume":"26","author":"Becker","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2020.01.100_b0130","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/joim.12159","article-title":"Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?","volume":"275","author":"Trifiro","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2020.01.100_b0135","unstructured":"Jerboa home page; 2018 [last accessed 28 March 2019]. Available from: https:\/\/github.com\/mi-erasmusmc\/Jerboa\/wiki."},{"key":"10.1016\/j.vaccine.2020.01.100_b0140","unstructured":"Bollearts K, Weil J, WP4 Working Group. D4.4 Report on tested methods for accelerated assessment of vaccination coverage, vaccine benefits, risks and benefit-risk; 2017 [last accessed 1 April 2019]. Available from: http:\/\/www.advance-vaccines.eu\/app\/archivos\/publicacion\/19\/ADVANCE_WP4_D4.4_submitted_.pdf."},{"key":"10.1016\/j.vaccine.2020.01.100_b0145","unstructured":"World Healh Organisation. WHO-UNICEF estimates of DTP3 coverage; 2018 [last accessed 29 March 2019]. Available from: http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/timeseries\/tswucoveragedtp3.html."},{"key":"10.1016\/j.vaccine.2020.01.100_b0150","doi-asserted-by":"crossref","first-page":"7364","DOI":"10.1016\/j.vaccine.2015.07.093","article-title":"The incidence of childhood and adolescent seizures in the UK from 1999 to 2011: a retrospective cohort study using the Clinical Practice Research Datalink","volume":"33","author":"Sammon","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0155","article-title":"Global and tegional burden of hospital admissions for pneumonia in older adults: a systematic review and meta-analysis","author":"Shi","year":"2019","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.01.100_b0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.2471\/BLT.07.048769","article-title":"Epidemiology and etiology of childhood pneumonia","volume":"86","author":"Rudan","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.01.100_b0165","first-page":"1189","article-title":"Data extraction and management in networks of observational health care databases for scientific research: a comparison of EU-ADR, OMOP, Mini-Sentinel and MATRICE strategies","volume":"4","author":"Gini","year":"2016","journal-title":"EGEMS (Washington, DC)"},{"key":"10.1016\/j.vaccine.2020.01.100_b0170","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.vaccine.2017.08.043","article-title":"Advancing collaborative vaccine benefits and safety research in Europe via the ADVANCE code of conduct","volume":"36","author":"Sturkenboom","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.01.100_b0175","unstructured":"European Health Data & Evidence Network (EHDEN); 2019 [last accessed 29 March 2019]. Available from: https:\/\/www.ehden.eu\/."},{"key":"10.1016\/j.vaccine.2020.01.100_b0180","unstructured":"Vac4Eu. Toolbox: benefits and risk; 2018 [last accessed 26 March 2019]. Available from: https:\/\/vac4eu.org\/brrota\/."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20301535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:36:02Z","timestamp":1759401362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20301535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":36,"alternative-id":["S0264410X20301535"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.100","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADVANCE database characterisation and fit for purpose assessment for multi-country studies on the coverage, benefits and risks of pertussis vaccinations","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.01.100","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}